Insights into the epidemiology of renal cell carcinoma in North Africa and the Middle East
Main Article Content
Abstract
Purpose - Recent improvements in the treatment of renal cell carcinoma (RCC), with the introduction of targeted agents, have increased the need of accurate data on its epidemiology. This descriptive study was designed to collate comprehensive
information on RCC epidemiology from North Africa and the Middle East, which could provide the basis for further research.
Methods - A network of reference oncologists in North Africa and the Middle East were invited to share all available national and regional information on RCC epidemiology, captured in a comprehensive questionnaire. No statistical analysis was
planned as the intention was to conduct a purely descriptive study.
Results - The results reported that the incidence of RCC within the region is in the range of 0.9–2.35/100,000 for men (with Lebanon as an exception at 4.3/100,000 for men) and 0.5– 1.7/100,000 for women, which is considerably lower than in Europe and the USA. No mortality or survival data are available. The age at diagnosis (mean <60 years) is lower than in Western countries and a high proportion of patients in North Africa and the Middle East (21?45%) have metastatic disease at diagnosis.
Conclusions - The information presented here provides a more complete and current picture of RCC in North Africa and the Middle East; however, there are still gaps in the data. Further research is needed to allow planning of treatment
strategies and resource allocation.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
A- Open Access statement and license:
1-Open Access statement:
JFMO provides immediate open access to published content in support of the idea that free access to research helps support the dissemination of knowledge and ideas in the field of medical science. All articles will be published under Creative Commons licenses.
All published data is immediate free access to the work and permits any user to read, download, copy, distribute print, search, or link to the full texts of articles.
The users of any published material in the JFMO must act in accordance with the Creative Commons Licenses CC BY-NC-ND 4.0.
2-License:
All published data is distributed following the Creative Commons Licenses CC BY-NC-ND 4.0. This license is allowing others to download the works and share them with others as long as they correctly cite the manuscript, No changes are allowed to the original manuscript and the manuscript must be used only for non for profit or non-commercial purposes.
This work is licensed under a Creative Commons AttributionNonCommercial-NoDerivatives 4.0 International License.
3-Self Archiving:
Authors are permitted and encouraged to share online their articles published in JFMO (e.g., in institutional repositories or on their website), as it can lead to productive exchanges, as well as earlier and greater citation of published work.
